JP2008517977A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008517977A5 JP2008517977A5 JP2007538414A JP2007538414A JP2008517977A5 JP 2008517977 A5 JP2008517977 A5 JP 2008517977A5 JP 2007538414 A JP2007538414 A JP 2007538414A JP 2007538414 A JP2007538414 A JP 2007538414A JP 2008517977 A5 JP2008517977 A5 JP 2008517977A5
- Authority
- JP
- Japan
- Prior art keywords
- cyclo
- dap
- trp
- phe
- leu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010021746 Infantile colic Diseases 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 239000002462 tachykinin receptor antagonist Substances 0.000 claims 6
- 239000005557 antagonist Substances 0.000 claims 5
- 235000013305 food Nutrition 0.000 claims 3
- 108010092101 MEN 11420 Proteins 0.000 claims 2
- 102000003141 Tachykinin Human genes 0.000 claims 2
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 claims 2
- 125000001488 beta-D-galactosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)* 0.000 claims 2
- NGCNKEZHGRXHNL-WVWQGFTISA-N n-[(2r,3r,4r,5s,6r)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-2-[(1s,4s,7s,10s,13s,16s)-13-benzyl-16-(1h-indol-3-ylmethyl)-7-(2-methylpropyl)-3,6,9,12,15,18,20-heptaoxo-2,5,8,11,14,17,21-heptazabicyclo[8.8.4]docosan-4-yl]acetamide Chemical compound C([C@H]1C(=O)N[C@H]2CC(=O)NC[C@H](NC(=O)[C@H](CC=3C=CC=CC=3)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC2=O)C(=O)N[C@H](C(N1)=O)CC(C)C)C(=O)N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O NGCNKEZHGRXHNL-WVWQGFTISA-N 0.000 claims 2
- 229950000640 nepadutant Drugs 0.000 claims 2
- 239000006188 syrup Substances 0.000 claims 2
- 235000020357 syrup Nutrition 0.000 claims 2
- 108060008037 tachykinin Proteins 0.000 claims 2
- 208000002881 Colic Diseases 0.000 claims 1
- 239000008267 milk Substances 0.000 claims 1
- 210000004080 milk Anatomy 0.000 claims 1
- 235000013336 milk Nutrition 0.000 claims 1
- 239000002746 neurokinin 2 receptor antagonist Substances 0.000 claims 1
- 239000008203 oral pharmaceutical composition Substances 0.000 claims 1
- 241000700159 Rattus Species 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000221A ITFI20040221A1 (it) | 2004-10-27 | 2004-10-27 | Composizioni farmaceutiche a base di nk2 antagonisti per uso pediatrico |
| ITFI2004A000221 | 2004-10-27 | ||
| PCT/EP2005/055575 WO2006045820A1 (en) | 2004-10-27 | 2005-10-26 | Pharmaceutical compositions based on nk2 antagonists for pediatric use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008517977A JP2008517977A (ja) | 2008-05-29 |
| JP2008517977A5 true JP2008517977A5 (enExample) | 2011-10-06 |
Family
ID=35613882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007538414A Pending JP2008517977A (ja) | 2004-10-27 | 2005-10-26 | 小児用nk2アンタゴニストに基づく製剤処方 |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US7727955B2 (enExample) |
| EP (1) | EP1809267B1 (enExample) |
| JP (1) | JP2008517977A (enExample) |
| CN (1) | CN101052386A (enExample) |
| AR (1) | AR051595A1 (enExample) |
| AT (1) | ATE422881T1 (enExample) |
| AU (1) | AU2005298629B2 (enExample) |
| CA (1) | CA2584481C (enExample) |
| CY (1) | CY1109803T1 (enExample) |
| DE (1) | DE602005012857D1 (enExample) |
| DK (1) | DK1809267T3 (enExample) |
| EA (1) | EA012264B1 (enExample) |
| ES (1) | ES2325413T3 (enExample) |
| HR (1) | HRP20090225T1 (enExample) |
| IT (1) | ITFI20040221A1 (enExample) |
| MX (1) | MX2007004461A (enExample) |
| NO (1) | NO338586B1 (enExample) |
| NZ (1) | NZ555380A (enExample) |
| PL (1) | PL1809267T3 (enExample) |
| PT (1) | PT1809267E (enExample) |
| RS (1) | RS50780B (enExample) |
| SI (1) | SI1809267T1 (enExample) |
| UA (1) | UA91988C2 (enExample) |
| WO (1) | WO2006045820A1 (enExample) |
| ZA (1) | ZA200703909B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0614970D0 (en) * | 2006-07-27 | 2006-09-06 | R & D Sosei Ltd | Compounds For Use In Therapy |
| IT1394304B1 (it) * | 2009-05-21 | 2012-06-06 | Malesci Sas | Processo per la preparazione di ibodutant (men15596) e relativi intermedi |
| ITRM20120331A1 (it) | 2012-07-12 | 2014-01-13 | Guidotti & C Spa Labor | Composizioni pediatriche orali liquide contenenti nepadutant. |
| US20160051596A1 (en) * | 2014-08-21 | 2016-02-25 | Food Industry Research And Development Institute | Novel acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase |
| US9867857B2 (en) | 2014-08-21 | 2018-01-16 | Food Industry Research And Development Institute | Acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0219318A (ja) * | 1988-06-30 | 1990-01-23 | Carl R Thornfeldt | 疝痛及び生歯に対する治療 |
| IT1277835B1 (it) * | 1995-03-13 | 1997-11-12 | Menarini Farma Ind | Composti biciclici, loro preparazione ed uso in composizioni farmaceutiche |
| IT1307809B1 (it) * | 1999-10-21 | 2001-11-19 | Menarini Ricerche Spa | Composti monociclici basici ad azione nk-2 antagonista, processi difabbricazione e formulazioni che li contengono. |
| MY130373A (en) * | 2001-10-29 | 2007-06-29 | Malesci Sas | Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| GB0224788D0 (en) * | 2002-10-24 | 2002-12-04 | Novartis Ag | Organic compounds |
-
2004
- 2004-10-27 IT IT000221A patent/ITFI20040221A1/it unknown
-
2005
- 2005-10-24 AR ARP050104429A patent/AR051595A1/es unknown
- 2005-10-26 HR HR20090225T patent/HRP20090225T1/xx unknown
- 2005-10-26 DE DE602005012857T patent/DE602005012857D1/de not_active Expired - Lifetime
- 2005-10-26 SI SI200530661T patent/SI1809267T1/sl unknown
- 2005-10-26 EA EA200700949A patent/EA012264B1/ru not_active IP Right Cessation
- 2005-10-26 ES ES05810894T patent/ES2325413T3/es not_active Expired - Lifetime
- 2005-10-26 UA UAA200705837A patent/UA91988C2/ru unknown
- 2005-10-26 PT PT05810894T patent/PT1809267E/pt unknown
- 2005-10-26 US US11/666,204 patent/US7727955B2/en not_active Expired - Fee Related
- 2005-10-26 CA CA2584481A patent/CA2584481C/en not_active Expired - Fee Related
- 2005-10-26 CN CNA2005800370703A patent/CN101052386A/zh active Pending
- 2005-10-26 AT AT05810894T patent/ATE422881T1/de active
- 2005-10-26 JP JP2007538414A patent/JP2008517977A/ja active Pending
- 2005-10-26 WO PCT/EP2005/055575 patent/WO2006045820A1/en not_active Ceased
- 2005-10-26 PL PL05810894T patent/PL1809267T3/pl unknown
- 2005-10-26 MX MX2007004461A patent/MX2007004461A/es active IP Right Grant
- 2005-10-26 RS RSP-2009/0169A patent/RS50780B/sr unknown
- 2005-10-26 AU AU2005298629A patent/AU2005298629B2/en not_active Ceased
- 2005-10-26 NZ NZ555380A patent/NZ555380A/en not_active IP Right Cessation
- 2005-10-26 EP EP05810894A patent/EP1809267B1/en not_active Expired - Lifetime
- 2005-10-26 DK DK05810894T patent/DK1809267T3/da active
-
2007
- 2007-05-15 ZA ZA200703909A patent/ZA200703909B/xx unknown
- 2007-05-29 NO NO20072720A patent/NO338586B1/no not_active IP Right Cessation
-
2009
- 2009-05-07 CY CY20091100493T patent/CY1109803T1/el unknown
-
2010
- 2010-04-19 US US12/799,176 patent/US20100234284A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2022035911A2 (en) | Methods of treating coronavirus infections by co-administering an fkbp ligand and an antiviral agent | |
| JP2007513190A5 (enExample) | ||
| CN104902905A (zh) | 药物组合物 | |
| JP2011502997A5 (enExample) | ||
| KR101420315B1 (ko) | 약학적 액제 조성물 | |
| CA3070660A1 (en) | Daptomycin formulations | |
| JP2015522033A5 (enExample) | ||
| JP2016020356A (ja) | 過増殖性疾患、自己免疫疾患、および心疾患の治療のための3−キヌクリジノンを含有する水溶液 | |
| MY144897A (en) | 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists | |
| JP2022031345A (ja) | St-246(テコビリマット一水和物)懸濁製剤 | |
| CN110996949A (zh) | 用于治疗行为改变的方法 | |
| JPWO2004066998A1 (ja) | 安定な経口用固形医薬組成物 | |
| JP2009521473A5 (enExample) | ||
| JP4513007B2 (ja) | 薬物吸収性改善剤 | |
| US20210038515A1 (en) | Composition and method for vancomycin oral liquid | |
| RU2007107368A (ru) | Композиция, содержащая десмопрессин | |
| JP2009007326A (ja) | フルニソリド含有粘膜適用組成物 | |
| JP2008517977A5 (enExample) | ||
| JP2006232675A (ja) | 複合型口腔内溶解用固形製剤 | |
| CN112312912A (zh) | 含有二胺衍生物的颗粒 | |
| JP6549428B2 (ja) | 経口組成物 | |
| HRP20220691T1 (hr) | Poboljšanja u i u vezi s pripravcima | |
| JP2001294524A (ja) | アセトアミノフェン配合内服固形製剤 | |
| ES2470333T3 (es) | Composiciones y métodos para aumentar los niveles de plaquetas de la sangre en humanos | |
| JP6554839B2 (ja) | 経口用組成物 |